Leonard S. Schleifer, President & CEO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 19,966 shares at $628.41 ($12.5M) on 2021-08-16, disclosed to the SEC on 2021-08-17.
Open-market sale of $12.5M REGN by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $615.54 | 171 | $105K | 0.8% |
| 2 | $615.54 | 171 | $105K | 0.8% |
| 3 | $616.70 | 146 | $90K | 0.7% |
| 4 | $616.70 | 146 | $90K | 0.7% |
| 5 | $617.79 | 258 | $159K | 1.3% |
| 6 | $617.79 | 258 |
| $159K |
| 1.3% |
| 7 | $618.82 | 90 | $56K | 0.4% |
| 8 | $618.82 | 90 | $56K | 0.4% |
| 9 | $619.83 | 34 | $21K | 0.2% |
| 10 | $620.36 | 96 | $60K | 0.5% |
| 11 | $620.36 | 96 | $60K | 0.5% |
| 12 | $621.76 | 287 | $178K | 1.4% |
| 13 | $621.76 | 287 | $178K | 1.4% |
| 14 | $622.44 | 924 | $575K | 4.6% |
| 15 | $622.44 | 924 | $575K | 4.6% |
| 16 | $623.66 | 2,393 | $1.5M | 12.0% |
| 17 | $623.66 | 2,393 | $1.5M | 12.0% |
| 18 | $624.42 | 1,862 | $1.2M | 9.3% |
| 19 | $624.42 | 1,862 | $1.2M | 9.3% |
| 20 | $625.19 | 1,355 | $847K | 6.8% |
| 21 | $625.19 | 1,355 | $847K | 6.8% |
| 22 | $626.15 | 295 | $185K | 1.5% |
| 23 | $626.15 | 295 | $185K | 1.5% |
| 24 | $627.51 | 1,111 | $697K | 5.6% |
| 25 | $627.51 | 1,111 | $697K | 5.6% |
| 26 | $628.41 | 675 | $424K | 3.4% |
| 27 | $628.41 | 675 | $424K | 3.4% |
| 28 | $629.54 | 303 | $191K | 1.5% |
| 29 | $629.54 | 303 | $191K | 1.5% |
| Total | $624.37 avg | 19,966 | $12.5M | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |